CAS 115104-28-4
:3-[[[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl][[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]propanoic acid
- 3-[({3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}{[3-(dimethylamino)-3-oxopropyl]sulfanyl}methyl)sulfanyl]propanoic acid
- 3-[[[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl][[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]propanoic Acid Sodium Salt
- 3-[[[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl][[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]propanoic acid
- 3-{[(R)-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}{[3-(dimethylamino)-3-oxopropyl]sulfanyl}methyl]sulfanyl}propanoic acid
- L 660711
- L 660711, Sodium Salt
- Mk-571
- Mk-571 Na
- Mk-571 Sodium Salt
- Mk-571, Na Salt
- Propanoic acid, 3-[[[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl][[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]-
- Propanoic acid, 3-[[[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl][[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]-, (E)-
- See more synonyms
Propanoic acid, 3-[[[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl][[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]-
CAS:Formula:C26H27ClN2O3S2Purity:95%Color and Shape:SolidMolecular weight:515.0872MK 571
CAS:MK 571 (L660711) is an orally active antagonist of CysLT1 receptor.Formula:C26H27ClN2O3S2Purity:98.69% - 99.65%Color and Shape:SolidMolecular weight:515.09Ref: TM-T7841
2mg34.00€5mg50.00€10mg81.00€25mg165.00€50mg285.00€100mg432.00€200mg617.00€1mL*10mM (DMSO)59.00€MK-571
CAS:Controlled ProductStability Hygroscopic
Applications A receptor antagonist for the treatment of respiratory diseases. Cysteinyl leukotriene receptor antagonist MK-571 alters bronchoalveolar lavage fluid proteome in asthma.
References Morgenstern, R., et al.: Biochem. J., 260, 577 (1989), Armstrong, R., et al.: Chem. Res. Toxicol., 10, 2 (1997), Larsen, J., et al.: Ann. Allergy, 71, 103 (1993),Formula:C26H26ClN2O3S2·NaColor and Shape:NeatMolecular weight:537.07MK 571
CAS:MK 571 is a drug that inhibits the ATP-binding cassette (ABC) transporter. MK 571 has been shown to inhibit leukotriene production in hl-60 cells and increase ATP release from myocardial infarcted hearts. It also inhibits the activity of nonsteroidal anti-inflammatory drugs and has been shown to have synergistic effects with other chemotherapeutic agents in cancer treatment.
Formula:C26H27ClN2O3S2Purity:Min. 95%Molecular weight:515.09 g/mol




